Keith H Wells

Insider

First SEC filing: Oct. 28, 2009 · Latest: Oct. 28, 2009

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 13, 2011	INO	A	35,000	$0.89	$31,150	35,000 Direct	—	Acquired	-97.1% (price as of 2026-08-20)
June 16, 2010	INO	A	35,000	$1.15	$40,250	35,000 Direct	—	Acquired	-97.7% (price as of 2026-08-20)
Oct. 26, 2009	INO	A	75,000	$1.20	$90,000	75,000 Direct	—	Acquired	-97.8% (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
May 13, 2011	INO	Common Stock Options	Common Stock (35,000)	$0.89	May 13, 2021	35,000	Acquired
June 16, 2010	INO	Common Stock Options	Common Stock (35,000)	$1.15	June 16, 2020	35,000	Acquired
Oct. 26, 2009	INO	Common Stock Options	Common Stock (75,000)	$1.20	Oct. 26, 2019	75,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Oct. 28, 2009	INO	Inovio Biomedical Corporation Common Stock Option [F1]→ Inovio Biomedical Corporation Common Stock (9,812)	9,812	Direct
Oct. 28, 2009	INO	Inovio Biomedical Corporation Common Stock Option [F1,F2]→ Inovio Biomedical Corporation Common Stock Option (7,850)	7,850	Direct